Myeloproliferative Neoplasms

Myeloproliferative Neoplasms News & Features

Long-Lived Patients With Primary Myelofibrosis: What Predicts a 20+ Year Survival?

By

Susan Moench, PhD, PA-C

Publish Date March 11, 2019

A retrospective study identified prognostic factors for long survival — 20+ years — in patients with primary myelofibrosis.

Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms

By

Susan Moench, PhD, PA-C

Publish Date February 15, 2019

A survey-based study investigated the relationship between symptom burden and incidence of medical disability leave among patients with MPNs.

Prevalence, Severity of Psychological Distress Higher in Patients Coping With Philadelphia-negative Myeloproliferative Neoplasm

By

Joyce Pagan

Publish Date January 22, 2019

Researchers sought to determine the prevalence and severity of anxiety and/or depression among patients with Philadelphia-negative MPNs.

No Benefit Achieved With Cytoreductive Therapy for Essential Thrombocythemia With Nonhigh Risk of Thrombosis

By

Tiffany Garbutt, PhD

Publish Date December 28, 2018

A study with more than 2000 patient-years follow-up, researchers found cytoreductive therapy was not as effective in patients with ET who have lower risk for thrombosis.

Recommended Therapies for Polycythemia Vera Underused

Publish Date December 4, 2018

Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients.